The nation of Zimbabwe has turned down a major US healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years over Washington's insistence on confidential information.
This rejection came to light after a internal memorandum from December was leaked, revealing that President Emmerson Mnangagwa believed the agreement was "unbalanced".
An official spokesman later stated that the United States was demanding access to health data for scientific study and commercial purposes while refused to share the resulting advantages from any future treatments.
"We will now turn to the challenging and unfortunate process of winding down our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has appealed for further negotiations to secure a deal agreeable to all parties so the country's vital HIV treatment initiative can proceed.
Broader Context
This rejection follows a similar case in Kenya, where a high court suspended a similar deal with the US after concerns were raised about the safety of citizens' medical information.
Since returning to office recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump claimed its spending was "inefficient" and his government was pursuing direct bilateral agreements to boost transparency and accountability.
Based on statements, 16 nations in Africa have so far agreed to similar agreements, constituting more than $18.3bn in committed funds.
Details of the Rejected Deal
The money for Zimbabwe was intended to supported "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"It is our view this partnership would have delivered immense benefits for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy through American-funded programmes," the Ambassador added.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"Zimbabwe was being asked to surrender its genetic material and health information indefinitely, with no corresponding promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that provided information," his statement read.
"Effectively, our country would provide the basic resources for scientific discovery without any assurance that the end products would be available to our citizens if a new disease outbreak emerge."
National Interest and Global Health
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral health agreements were undermining systems previously set up via the global organization.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme created to deal with potential global health emergencies.
"This mechanism is designed to guarantee that when a nation provides its information, the benefits – including medicines and cures – are shared equitably, not monopolised exclusively by those with the funds to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," Mangwana stressed.
"We encourage ongoing dialogue with our US partners on how future collaboration might be designed in a way that honours the independence and interests of each country."
Medical Community Reaction
Medical experts said it acknowledged the official position, but recommended that negotiations must proceed given that much of the country's HIV programmes were funded by international support.
"If specific concerns arise, including those involving data governance or agreement terms, these can often be resolved via detailed discussion and negotiated safeguards," it added.
The halted deal underscores the complex debate between receiving much-needed foreign assistance and protecting local interests in an ever more data-driven world.